Kerry Group PLC (LON:KYGA) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $108.00. Kerry Group shares last traded at $107.30, with a volume of 10,952 shares traded.
Separately, Barclays restated a “hold” rating and issued a $52.00 price objective on shares of Biohaven Pharmaceutical in a report on Tuesday, March 19th.
The business has a fifty day moving average of GBX 3,020.76. The stock has a market cap of $189.01 million and a PE ratio of 35.03. The company has a current ratio of 1.38, a quick ratio of 0.84 and a debt-to-equity ratio of 53.02.
Kerry Group plc, together with its subsidiaries, develops, manufactures, and delivers technology based taste and nutrition solutions for the food, beverage, and pharmaceutical industries in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Taste & Nutrition and Consumer Foods.
Receive News & Ratings for Kerry Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kerry Group and related companies with MarketBeat.com's FREE daily email newsletter.